NewSquare Capital’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-4
Closed -$101 – 878
2023
Q2
$101 Hold
4
– – ﹤0.01% 794
2023
Q1
$104 Hold
4
– – ﹤0.01% 823
2022
Q4
$95 Buy
+4
New +$108 ﹤0.01% 772
2022
Q1
– Sell
-296
Closed -$27K – 464
2021
Q4
$27K Hold
296
– – ﹤0.01% 225
2021
Q3
$38K Hold
296
– – ﹤0.01% 209
2021
Q2
$49K Hold
296
– – 0.01% 197
2021
Q1
$54K Hold
296
– – 0.01% 175
2020
Q4
$59K Sell
296
-10,433
-97% -$2.12M 0.01% 174
2020
Q3
$2.35M Buy
10,729
+2,539
+31% +$538K 0.38% 69
2020
Q2
$1.56M Buy
8,190
+1,470
+22% +$258K 0.27% 84
2020
Q1
$1.04M Buy
+6,720
New +$782K 0.19% 92

Other funds holding TDOC

NewSquare Capital's TDOC Position: Q3 2023 in Review

NewSquare Capital sold out of Teladoc Health (TDOC) in Q3 2023, closing a stake of 4 shares — an estimated $101 sold.

NewSquare Capital first reported a position in TDOC in Q1 2020 and held it in 11 quarters. The position peaked at $2.35M in Q3 2020. 436 funds tracked by Wall St. Rank hold TDOC as of Q3 2023.

  • NewSquare Capital reported no remaining Teladoc Health position as of Q3 2023 after selling out during the quarter.
  • NewSquare Capital sold 4 Teladoc Health shares in Q3 2023, an estimated $101.
  • NewSquare Capital first reported a position in Teladoc Health in Q1 2020 and held it in 11 quarters.
  • NewSquare Capital's Teladoc Health position peaked at $2.35M in Q3 2020.
  • 436 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2023.

Based on NewSquare Capital's 13F filing for Q3 2023, filed 3 Nov 2023.